Use of Human Lung Tissue Models for Screening of Drugs against SARS-CoV-2 Infection

The repurposing of licenced drugs for use against COVID-19 is one of the most rapid ways to develop new and alternative therapeutic options to manage the ongoing pandemic. Given circa 7817 licenced compounds available from Compounds Australia that can be screened, this paper demonstrates the utility...

Descripción completa

Detalles Bibliográficos
Autores principales: McAuley, Alexander J., Jansen van Vuren, Petrus, Mohammed, Muzaffar-Ur-Rehman, Faheem, Goldie, Sarah, Riddell, Shane, Gödde, Nathan J., Styles, Ian K., Bruce, Matthew P., Chahal, Simran, Keating, Stephanie, Blasdell, Kim R., Tachedjian, Mary, O’Brien, Carmel M., Singanallur, Nagendrakumar Balasubramanian, Viana, John Noel, Vashi, Aditya V., Kirkpatrick, Carl M., MacRaild, Christopher A., Shah, Rohan M., Vincan, Elizabeth, Athan, Eugene, Creek, Darren J., Trevaskis, Natalie L., Murugesan, Sankaranarayanan, Kumar, Anupama, Vasan, Seshadri S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693925/
https://www.ncbi.nlm.nih.gov/pubmed/36366514
http://dx.doi.org/10.3390/v14112417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693925/
https://www.ncbi.nlm.nih.gov/pubmed/36366514
http://dx.doi.org/10.3390/v14112417

Ejemplares similares